↓ Skip to main content

Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta‐blockers

Overview of attention for article published in European Journal of Heart Failure, March 2010
Altmetric Badge

Mentioned by

f1000
1 research highlight platform

Citations

dimensions_citation
67 Dimensions

Readers on

mendeley
107 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta‐blockers
Published in
European Journal of Heart Failure, March 2010
DOI 10.1093/eurjhf/hfq032
Pubmed ID
Authors

Claes-Håkan Bergh, Bert Andersson, Ulf Dahlström, Kolbjorn Forfang, Matti Kivikko, Toni Sarapohja, Bengt Ullman, Gerhard Wikström

Abstract

The aim of this study is to compare the effects of a 24 h intravenous infusion of levosimendan and a 48 h infusion of dobutamine on invasive haemodynamics in patients with acutely decompensated chronic NYHA class III-IV heart failure. All patients were receiving optimal oral therapy including a beta-blocker.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 107 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 2 2%
Italy 1 <1%
Hong Kong 1 <1%
United Kingdom 1 <1%
Belgium 1 <1%
Spain 1 <1%
Unknown 100 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 18 17%
Student > Master 16 15%
Other 12 11%
Student > Postgraduate 10 9%
Professor 9 8%
Other 30 28%
Unknown 12 11%
Readers by discipline Count As %
Medicine and Dentistry 83 78%
Nursing and Health Professions 3 3%
Pharmacology, Toxicology and Pharmaceutical Science 2 2%
Biochemistry, Genetics and Molecular Biology 1 <1%
Unspecified 1 <1%
Other 4 4%
Unknown 13 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2010.
All research outputs
#17,700,438
of 25,837,817 outputs
Outputs from European Journal of Heart Failure
#2,120
of 2,611 outputs
Outputs of similar age
#88,858
of 107,326 outputs
Outputs of similar age from European Journal of Heart Failure
#15
of 15 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,611 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 107,326 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.